AJP - Endocrinology and Metabolism, Vol 254, Issue 6 E795-E798, Copyright © 1988 by American Physiological Society

ARTICLES

Characterization of beta-adrenergic receptors of human skeletal muscle obtained by needle biopsy

S. B. Liggett, S. D. Shah and P. E. Cryer
Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110.

Human skeletal muscle beta-adrenergic receptors were characterized by 125I-iodopindolol radioligand-binding studies of homogenates prepared from small muscle samples obtained by percutaneous needle biopsy from the gastrocnemius of six normal subjects. Binding was saturable, reversible, and stereospecific, with typical kinetics and a rank-order potency characteristic of a beta-adrenergic receptor. In saturation-binding studies, the receptor density was 9.7 +/- 1.9 fmol/mg protein, with a dissociation constant of 24 +/- 2.2 pM. Competition studies with selective antagonists revealed a population of receptors exclusively of the beta 2-subtype. Basal and isoproterenol-stimulated adenylate cyclase activities were 79 +/- 22 and 150 +/- 60 pmol adenosine 3',5'-cyclic monophosphate.min-1.mg protein-1, respectively. These results support pharmacological observations of beta-adrenergic receptor-mediated cellular responses in mammalian skeletal muscle. By use of these methods, small quantities of skeletal muscle obtained in this manner can be used to study in vivo beta-adrenergic receptor regulatory phenomena in humans.

This article has been cited by other articles:

				A. C. Fry, B. K. Schilling, L. W. Weiss, and L. Z. F. Chiu beta2-Adrenergic receptor downregulation and performance decrements during high-intensity resistance exercise overtraining J Appl Physiol, December 1, 2006; 101(6): 1664 - 1672. [Abstract] [Full Text] [PDF]

				J. Hoeks, M. A. van Baak, M. K. C. Hesselink, G. B. Hul, H. Vidal, W. H. M. Saris, and P. Schrauwen Effect of {beta}1- and {beta}2-adrenergic stimulation on energy expenditure, substrate oxidation, and UCP3 expression in humans Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E775 - E782. [Abstract] [Full Text] [PDF]

				J.-F. Desaphy, S. Pierno, A. De Luca, P. Didonna, and D. C. Camerino Different Ability of Clenbuterol and Salbutamol to Block Sodium Channels Predicts Their Therapeutic Use in Muscle Excitability Disorders Mol. Pharmacol., March 1, 2003; 63(3): 659 - 670. [Abstract] [Full Text] [PDF]

				M. B. Lortie and T. W. Moon The rainbow trout skeletal muscle beta -adrenergic system: characterization and signaling Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2003; 284(3): R689 - R697. [Abstract] [Full Text] [PDF]

				E. Hagstrom-Toft, S. Enoksson, E. Moberg, J. Bolinder, and P. Arner beta -Adrenergic regulation of lipolysis and blood flow in human skeletal muscle in vivo Am J Physiol Endocrinol Metab, December 1, 1998; 275(6): E909 - E916. [Abstract] [Full Text] [PDF]

				S. J. Peters, D. J. Dyck, A. Bonen, and L. L. Spriet Effects of epinephrine on lipid metabolism in resting skeletal muscle Am J Physiol Endocrinol Metab, August 1, 1998; 275(2): E300 - E309. [Abstract] [Full Text] [PDF]